- The Fiscal
- What We're
- What You
The search found 86 results in 0.034 seconds.
The coronavirus (COVID-19) pandemic has caused federal spending on Medicaid to rise sharply as millions of Americans seek benefits under the program.
The cost and quality of the U.S. healthcare system is one of the most prominent issues facing everyday Americans. It is a top policy concern for voters, a key indicator of economic efficiency, and a significant driver of the national debt.
The growing cost of prescription drugs presents a significant challenge to the quality and affordability of healthcare in the United States.
Despite higher healthcare spending per capita, the U.S. generally does not have better health outcomes.
Healthcare expenditures in the U.S. are much higher than those of other developed countries.
Although the United States spends more on healthcare than other developed countries, its health outcomes are generally no better.
United States per capita healthcare spending is nearly three times the average of other developed countries.
America’s economic rebound from the coronavirus pandemic seems to have begun, depending on location, according to Phillip Swagel, the director of the nonpartisan Congressional Budget Office.
The latest Financial Times-Peterson Foundation US Economic Monitor, released on June 4, 2020, reveals how the coronavirus pandemic continues to have significant financial and economic impacts across wide swaths of American society.